InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by STEVEN PIEPER. Director active across 1 company, notably Xeris Biopharma Holdings, Inc.. Cumulatively, 2 reports have been published. History available since 6 July 2026. The latest transaction was disclosed on 7 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations